Norovirus in symptomatic and asymptomatic individuals: Cytokines and viral shedding

Clinical and Experimental Immunology

Volumn 184, Issue 3, 2016, Pages 347-357

  Newman, K L ^a,b   Moe, C L ^a   Kirby, A E ^a   Flanders, W D ^a   Parkos, C A ^c   Leon, J S ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Adaptive immunity; Caliciviruses; Gastroenteritis; Innate immunity; Symptoms

Indexed keywords

ALPHA2 INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; IL6 PROTEIN, HUMAN; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; NOROVIRUS INFECTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH2 CELL; VIRUS LOAD; VIRUS SHEDDING; ADOLESCENT; ASYMPTOMATIC DISEASE; BLOOD; CHEMISTRY; FECES; GASTROENTERITIS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INNATE IMMUNITY; NOROVIRUS; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; TH1 TH2 BALANCE; VIROLOGY;

ADOLESCENT; ADULT; ASYMPTOMATIC DISEASES; FECES; FEMALE; GASTROENTERITIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-6; INTERLEUKIN-8; MALE; NOROVIRUS; RNA, VIRAL; SEVERITY OF ILLNESS INDEX; TH1 CELLS; TH1-TH2 BALANCE; TH2 CELLS; VIRAL LOAD; VIRUS SHEDDING;

EID: 84959449327     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12772     Document Type: Article

References (42)

1. Ahmed SM, Hall AJ, Robinson AE et al. Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. Lancet Infect Dis 2014; 14:725-30.
2. Green KY. Norovirus infection in immunocompromised hosts. Clin Microbiol Infect 2014; 20:717-23.
3. Gustavsson L, Andersson LM, Lindh M, Westin J. Excess mortality following community-onset norovirus enteritis in the elderly. J Hosp Infect 2011; 79:27-31.
4. Desai R, Hembree CD, Handel A et al. Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review. Clin Infect Dis 2012; 55:189-93.
5. Atmar RL, Opekun AR, Gilger MA et al. Norwalk virus shedding after experimental human infection. Emerg Infect Dis 2008; 14:1553-7.
6. Kirby AE, Shi J, Montes J, Lichtenstein M, Moe CL. Disease course and viral shedding in experimental Norwalk virus and Snow Mountain virus infection. J Med Virol 2014; 86:2055-64.
7. Sukhrie FH, Teunis P, Vennema H et al. Nosocomial transmission of norovirus is mainly caused by symptomatic cases. Clin Infect Dis 2012; 54:931.
8. Zelner JL, Lopman BA, Hall AJ, Ballesteros S, Grenfell BT. Linking time-varying symptomatology and intensity of infectiousness to patterns of norovirus transmission. PLoS One 2013; 8:e68413.
9. Newman KL, Leon JS. Norovirus immunology: of mice and mechanisms. Eur J Immunol 2015; 45:2742-57.
10. Bernstein DI, Atmar RL, Lyon GM et al. Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults. J Infect Dis 2015; 211:870-8.
11. Atmar RL, Bernstein DI, Harro CD et al. Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med 2011; 365:2178-87.
12. Newman KL, Moe CL, Kirby AE, Flanders WD, Parkos CA, Leon JS. Human norovirus infection and the acute serum cytokine response. Clin Exp Immunol 2015; 182:195-203.
13. Teunis PF, Sukhrie FH, Vennema H, Bogerman J, Beersma MF, Koopmans MP. Shedding of norovirus in symptomatic and asymptomatic infections. Epidemiol Infect 2015; 143:1710-7.
14. Leon JS, Kingsley DH, Montes JS et al. Randomized, double-blinded clinical trial for human norovirus inactivation in oysters by high hydrostatic pressure processing. Appl Environ Microbiol 2011; 77:5476-82.
15. Seitz SR, Leon JS, Schwab KJ et al. Norovirus infectivity in humans and persistence in water. Appl Environ Microbiol 2011; 77:6884-8.
16. Liu P, Hsiao HM, Jaykus LA, Moe C. Quantification of Norwalk virus inocula: comparison of endpoint titration and real-time reverse transcription-PCR methods. J Med Virol 2010; 82:1612-16.
17. Wong HL, Pfeiffer RM, Fears TR, Vermeulen R, Ji S, Rabkin CS. Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiol Biomarkers Prev 2008; 17:3450-6.
18. Lindesmith L, Moe C, Lependu J, Frelinger JA, Treanor J, Baric RS. Cellular and humoral immunity following Snow Mountain virus challenge. J Virol 2005; 79:2900-9.
19. Jiang B, Snipes-Magaldi L, Dennehy P et al. Cytokines as mediators for or effectors against rotavirus disease in children. Clin Diagn Lab Immunol 2003; 10:995-1001.
20. Azim T, Zaki MH, Podder G et al. Rotavirus-specific subclass antibody and cytokine responses in Bangladeshi children with rotavirus diarrhoea. J Med Virol 2003; 69:286-95.
21. Lian JQ, Yang XF, Zhao RR et al. Expression profiles of circulating cytokines, chemokines and immune cells in patients with hepatitis B virus infection. Hepat Mon 2014; 14:e18892.
22. Yeo AS, Azhar NA, Yeow W et al. Lack of clinical manifestations in asymptomatic dengue infection is attributed to broad down-regulation and selective up-regulation of host defence response genes. PLoS One 2014; 9:e92240.
23. Reisinger EC, Fritzsche C, Krause R, Krejs GJ. Diarrhea caused by primarily non-gastrointestinal infections. Nat Clin Pract Gastroenterol Hepatol 2005; 2:216-22.
24. Wang J, Li FQ, Wei HM, Lian ZX, Sun R, Tian ZG. Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation. J Exp Med 2014; 211:2397-410.
25. Mehta SK, Crucian BE, Stowe RP et al. Reactivation of latent viruses is associated with increased plasma cytokines in astronauts. Cytokine 2013; 61:205-9.
26. Mumphrey SM, Changotra H, Moore TN et al. Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses. J Virol 2007; 81:3251-63.
27. Karst SM, Wobus CE, Lay M, Davidson J, Virgin HW IV. STAT1-dependent innate immunity to a Norwalk-like virus. Science 2003; 299:1575-8.
28. McFadden N, Bailey D, Carrara G et al. Norovirus regulation of the innate immune response and apoptosis occurs via the product of the alternative open reading frame 4. PLOS Pathog 2011; 7:e1002413.
29. Gustavsson L, Skovbjerg S, Lindh M, Westin J, Andersson LM. Low serum levels of CCL5 are associated with longer duration of viral shedding in norovirus infection. J Clin Virol 2015; 69:133-7.
30. Marques RE, Guabiraba R, Russo RC, Teixeira MM. Targeting CCL5 in inflammation. Expert Opin Ther Targets 2013; 17:1439-60.
31. Troeger H, Loddenkemper C, Schneider T et al. Structural and functional changes of the duodenum in human norovirus infection. Gut 2009; 58:1070-7.
32. Souza M, Azevedo MS, Jung K, Cheetham S, Saif LJ. Pathogenesis and immune responses in gnotobiotic calves after infection with the genogroup II.4-HS66 strain of human norovirus. J Virol 2008; 82:1777-86.
33. Cheetham S, Souza M, Meulia T, Grimes S, Han MG, Saif LJ. Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs. J Virol 2006; 80:10372-81.
34. Chachu KA, LoBue AD, Strong DW, Baric RS, Virgin HW. Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection. PLoS Pathog 2008; 4:e1000236.
35. Chachu KA, Strong DW, LoBue AD, Wobus CE, Baric RS, Virgin HW IV. Antibody is critical for the clearance of murine norovirus infection. J Virol 2008; 82:6610-7.
36. Navaneethan U, Giannella RA. Mechanisms of infectious diarrhea. Nat Clin Pract Gastroenterol Hepatol 2008; 5:637-47.
37. Martina BE. Dengue pathogenesis: a disease driven by the host response. Sci Prog 2014; 97:197-214.
38. Lindesmith L, Moe C, Marionneau S et al. Human susceptibility and resistance to Norwalk virus infection. Nat Med 2003; 9:548-53.
39. Saif MA, Bonney DK, Bigger B et al. Chronic norovirus infection in pediatric hematopoietic stem cell transplant recipients: a cause of prolonged intestinal failure requiring intensive nutritional support. Pediatr Transplant 2011; 15:505-9.
40. Lindesmith LC, Donaldson E, Leon J et al. Heterotypic humoral and cellular immune responses following Norwalk virus infection. J Virol 2010; 84:1800-15.
41. Baldridge MT, Nice TJ, McCune BT et al. Commensal microbes and interferon-lambda determine persistence of enteric murine norovirus infection. Science 2015; 347:266-9.
42. Osborne LC, Monticelli LA, Nice TJ et al. Coinfection. Virus-helminth coinfection reveals a microbiota-independent mechanism of immunomodulation. Science 2014; 345:578-82.